HST Global, Inc. income statement HSTC

Annual Quarterly

In fiscal 2023, which ended Dec 31, 2023, HST Global, Inc. reported revenue of $0. It recorded a net loss of $146,210. Over the twelve months ended Sep 30, 2024, revenue was $0 and the net loss was $101,508.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2024 Sep 30, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016	FY 2015 Dec 31, 2015	FY 2013 Dec 31, 2013
Revenue	0	0	0	0	0	0	0	—	—	—	—
Selling, general and administrative	0 +90.4%	0 -0.6%	0 -18.2%	0 -8.1%	0 -60.8%	0 +215.9%	0 -31.5%	0 +91.0%	0 -56.9%	0	0 -83.2%
Operating income	-0 +29.9%	-0 +0.1%	-0 +3.2%	-0 +29.9%	-0 -37.2%	-0 -6.3%	-0 +6.8%	-0 -11.5%	-0 +14.2%	-0	-0 +54.0%
Income tax	0	0	0	0	0	0	0	—	—	—	—
Net income	-0 +30.0%	-0 -0.8%	-0 +2.2%	-0 +29.0%	-0 -149.0%	0 +339.2%	-0 -8.0%	-0 +4.6%	-0 +11.6%	-0	-0 +48.7%
Basic EPS	-0.00 +82.3%	-0.03 +0.0%	-0.03	—	—	—	—	—	—	—	—
Weighted average shares, basic	21 +296.4%	5 +0.0%	5	—	—	—	—	—	—	—	—
Other measures
Interest coverage	-28.93x	-26.57x	-34.92x	-55.15x	-205.11x	-8.48x	-3.99x	—	—	-4.48x	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: HSTC (OTC)
Fiscal year ends: December 31
Incorporated in: NV
Headquarters: Virginia Beach, VA
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 797564
Former names: NT HOLDING CORP. (until Mar 31, 2009); ABSS CORP (until Aug 12, 2004); UNICO INC (until May 22, 2002)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.